Ownership Summary
A total of 9 institutions have reported a stake in Pharming Group N.V. (NASDAQ:PHAR) as of December 2025, according to recent 13F filings with the SEC.
- Pharming saw its institutional ownership percentage rose to 0.1% in December 2025 from 0.1% in September 2025.
- Quarterly data indicates a 90.95% shift in institutional share volume, and the annual owner count reflects an increase of 50.00%.
- Of these 9 institutional investors, 6 increased their holdings in Pharming, while 2 of them reduced positions, and 1 investors maintained their exposure.
- This class of investors increased its holdings in Pharming to 110.72K shares for the 13F-cycle ending December 2025, up by 52.73K shares quarter on quarter, and up 59.62K shares year over year.
- The top institutional stake in Pharming as of December 31, 2025 belongs to Silverberg Bernstein Capital Management LLC, which owns 50.55K shares, or 0.06% of the company.
- Among the most significant buyers of Pharming during December 2025 were MILLENNIUM MANAGEMENT LLC (20.39K), CITADEL ADVISORS LLC (17.69K), SmartHarvest Portfolios, LLC (12.69K), MORGAN STANLEY (3.35K), BNP PARIBAS FINANCIAL MARKETS (700).
- Leading sellers of Pharming stock in December 2025 included Silverberg Bernstein Capital Management LLC (1.60K), EverSource Wealth Advisors, LLC (473).
- The top 9 institutional holders of Pharming for the quarter ending December 2025 included Silverberg Bernstein Capital Management LLC (50.55K), MILLENNIUM MANAGEMENT LLC (20.39K), CITADEL ADVISORS LLC (17.69K), SmartHarvest Portfolios, LLC (12.69K), MORGAN STANLEY (7.70K), EverSource Wealth Advisors, LLC (904), BNP PARIBAS FINANCIAL MARKETS (800), BESSEMER GROUP INC (3), UBS Group AG (1).